What two components make up the medication Kazano?

Kazano is a fixed-dose combination medication specifically indicated for the management of type 2 diabetes. It contains two active ingredients: metformin, which is a biguanide that helps to reduce glucose production in the liver and increase insulin sensitivity, and alogliptin, which is a DPP-4 inhibitor that works by increasing the levels of incretin hormones to lower blood sugar levels after meals.

This combination helps to effectively control blood sugar levels while addressing different aspects of glucose metabolism, making it a synergistic choice for patients who require thorough management of their diabetes. The use of both metformin and alogliptin in Kazano helps to maximize the therapeutic effects while minimizing potential side effects associated with each individual medication.